186 accepted testing records were counted. Held and rejected records stayed out.
Standard grade
Testing, transparency, and catalog integrity data were observed and scored on the current 100-point rubric. Public discussion is not included in the score.
Grade and evidence review: Sep 12, 2026.
How the grade was built · Sep 12, 2026
186 accepted testing records were counted. Held and rejected records stayed out.
8 public identity, policy, catalog, or testing pages were successfully checked.
Listing resolution, exact-basis coverage, freshness, and testing traceability contributed 22 points in the Sep 12, 2026 review.
Public discussion is context only and does not affect this score. Catalog integrity supplies the 30-point third component. Price updates do not change this dated grade.
Open the detailed evidence summary →Catalog and recorded prices
Catalog listings reflect the Sep 12, 2026 review. Price and stock observations can change; compare the exact product and confirm availability with the vendor.
| Compound | Catalog listings | Recorded offers | In stock when observed | Lowest effective price | That price observed | Compare |
|---|---|---|---|---|---|---|
| 5-Amino-1MQ | 2 | 0 | Not recorded | Not available | Not available | View record → |
| Adamax | 2 | 0 | Not recorded | Not available | Not available | View record → |
| AHK-Cu | 1 | 0 | Not recorded | Not available | Not available | View record → |
| AOD-9604 | 1 | 0 | Not recorded | Not available | Not available | View record → |
| ARA-290 | 1 | 1 | 0 | $5710 mg vialOut of stock when observed | Sep 21, 2026 | Compare this product → |
| BPC-157 | 2 | 0 | Not recorded | Not available | Not available | View record → |
| Cagrilintide | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Cerebrolysin | 1 | 1 | 1 | $52.5060 mg vial | Sep 21, 2026 | Compare this product → |
| CJC-1295 | 1 | 1 | 1 | $6010 mg vial | Sep 21, 2026 | Compare this product → |
| CJC-1295/Ipamorelin Blend | 1 | 1 | 1 | $78.7520 mg vial | Sep 21, 2026 | Compare this product → |
| DSIP | 1 | 1 | 1 | $33.755 mg vial | Sep 21, 2026 | Compare this product → |
| Eloralintide | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Epithalon | 1 | 1 | 0 | $33.7510 mg vialOut of stock when observed | Sep 21, 2026 | Compare this product → |
| FOXO4-DRI | 1 | 1 | 1 | $123.7510 mg vial | Sep 21, 2026 | Compare this product → |
| GHK-Cu | 2 | 1 | 1 | $37.50100 mg vial | Sep 21, 2026 | Compare this product → |
| GLOW Blend (GHK-Cu/BPC-157/TB-500) | 1 | 1 | 0 | $74.2570 mg vialOut of stock when observed | Sep 21, 2026 | Compare this product → |
| Glutathione | 3 | 2 | 2 | $52.501200 mg vial | Sep 21, 2026 | Compare this product → |
| HGH Fragment 176-191 | 1 | 1 | 0 | $59.255 mg vialOut of stock when observed | Sep 21, 2026 | Compare this product → |
| IGF-1 LR3 | 1 | 1 | 0 | $56.251 mg vialOut of stock when observed | Sep 21, 2026 | Compare this product → |
| Ipamorelin | 1 | 1 | 1 | $4510 mg vial | Sep 21, 2026 | Compare this product → |
| Kisspeptin-10 | 1 | 1 | 1 | $33.7510 mg vial | Sep 21, 2026 | Compare this product → |
| KLOW Blend (GHK-Cu/BPC-157/TB-500/KPV) | 1 | 1 | 1 | $9080 mg vial | Sep 21, 2026 | Compare this product → |
| KPV | 1 | 1 | 1 | $37.5010 mg vial | Sep 21, 2026 | Compare this product → |
| LL-37 | 1 | 1 | 1 | $44.255 mg vial | Sep 21, 2026 | Compare this product → |
| Mazdutide | 1 | 1 | 1 | $74.2510 mg vial | Sep 21, 2026 | Compare this product → |
| Melanotan I | 1 | 1 | 1 | $3910 mg vial | Sep 21, 2026 | Compare this product → |
| Melanotan II | 1 | 1 | 1 | $3910 mg vial | Sep 21, 2026 | Compare this product → |
| Methylene Blue | 1 | 0 | Not recorded | Not available | Not available | View record → |
| MOTS-c | 1 | 0 | Not recorded | Not available | Not available | View record → |
| NAD+ | 1 | 0 | Not recorded | Not available | Not available | View record → |
| PE-22-28 | 1 | 1 | 1 | $6010 mg vial | Sep 21, 2026 | Compare this product → |
| Pinealon | 1 | 1 | 1 | $56.2510 mg vial | Sep 21, 2026 | Compare this product → |
| PT-141 (Bremelanotide) | 1 | 1 | 1 | $41.2510 mg vial | Sep 21, 2026 | Compare this product → |
| Retatrutide | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Retatrutide/Cagrilintide Blend | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Selank | 2 | 1 | 1 | $3310 mg vial | Sep 21, 2026 | Compare this product → |
| Semax | 2 | 1 | 1 | $3310 mg vial | Sep 21, 2026 | Compare this product → |
| Sermorelin | 1 | 1 | 0 | $6310 mg vialOut of stock when observed | Sep 21, 2026 | Compare this product → |
| SLU-PP-332 | 1 | 0 | Not recorded | Not available | Not available | View record → |
| TB-500 | 2 | 1 | 0 | $4510 mg vialOut of stock when observed | Sep 21, 2026 | Compare this product → |
| Tesamorelin | 1 | 1 | 1 | $59.2510 mg vial | Sep 21, 2026 | Compare this product → |
| Tesamorelin/Ipamorelin Blend | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Tesofensine | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Thymosin Alpha-1 | 2 | 1 | 0 | $56.2510 mg vialOut of stock when observed | Sep 21, 2026 | Compare this product → |
| Thymulin | 1 | 1 | 1 | $93.7510 mg vial | Sep 21, 2026 | Compare this product → |
| Tirzepatide | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Wolverine Blend (BPC-157/TB-500) | 1 | 1 | 0 | $4810 mg vialOut of stock when observed | Sep 21, 2026 | Compare this product → |